HC
XENT

Henshaw Capital’s Intersect ENT, Inc XENT Stock Holding History

Henshaw Capital’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,759
Closed -$253K – 338
2017
Q1 		$253K Buy
14,759
+1,445
+11% +$20.2K 0.03% 243
2016
Q4 		$161K Hold
13,314
– – 0.02% 269
2016
Q3 		$211K Hold
13,314
– – 0.03% 254
2016
Q2 		$172K Hold
13,314
– – 0.02% 255
2016
Q1 		$253K Buy
+13,314
New +$241K 0.03% 223

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Henshaw Capital's XENT Position: Q2 2017 in Review

Henshaw Capital sold out of Intersect ENT, Inc (XENT) in Q2 2017, closing a stake of 14,759 shares — an estimated $253K sold.

Henshaw Capital first reported a position in XENT in Q1 2016 and held it in 5 quarters. The position peaked at $253K in Q1 2017. 128 funds tracked by Wall St. Rank hold XENT as of Q2 2017.

  • Henshaw Capital reported no remaining Intersect ENT, Inc position as of Q2 2017 after selling out during the quarter.
  • Henshaw Capital sold 14,759 Intersect ENT, Inc shares in Q2 2017, an estimated $253K.
  • Henshaw Capital first reported a position in Intersect ENT, Inc in Q1 2016 and held it in 5 quarters.
  • Henshaw Capital's Intersect ENT, Inc position peaked at $253K in Q1 2017.
  • 128 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2017.

Based on Henshaw Capital's 13F filing for Q2 2017, filed 28 May 2026.